Pure Global

Anti-beta2-Glycoprotein I Control - India CDSCO Medical Device Registration

Anti-beta2-Glycoprotein I Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000088_d05119f1037938dacad337429117f779_0f5cc18ccb11e122848e77feec22374a. This device is marketed under the brand name IAA Control. The license holder is M/s. CPC Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Anti-beta2-Glycoprotein I Control
UID: IMP/IVD/2022/000088_d05119f1037938dacad337429117f779_0f5cc18ccb11e122848e77feec22374a

Brand Name

IAA Control

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Anti-beta2-Glycoprotein I Control is intended for use as an assayed quality control sample to monitor the performance of the immunoassays for Anti-ฮฒ2-Glycoprotein I on the iFlash systems.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing